Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Nischarin | ||
Ligand | BDBM50001028 | ||
Substrate/Competitor | n/a | ||
Ki | >10000±n/a nM | ||
Comments | PDSP_1451 | ||
Citation | Molderings, GJ; Donecker, K; Burian, M; Simon, WA; Schröder, DW; Göthert, M Characterization of I2 imidazoline and sigma binding sites in the rat and human stomach. J Pharmacol Exp Ther285:170-7 (1998) [PubMed] | ||
More Info.: | Get all data from this article | ||
Nischarin | |||
Name: | Nischarin | ||
Synonyms: | Imidazoline I1 | NISCH_RAT | Nisch | Nischarin | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 166460.59 | ||
Organism: | RAT | ||
Description: | Q4G017 | ||
Residue: | 1502 | ||
Sequence: |
| ||
BDBM50001028 | |||
n/a | |||
Name | BDBM50001028 | ||
Synonyms: | (+)-PENTAZOCINE | (-)-pentazocine | (2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol | (6R,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol | 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol | 6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Pentazocine) | CHEMBL560 | PENTAZOCINE (+) | PENTAZOCINE (-) | Pentazocine | Pentazocine,(+/-) | Talacen | Talwin | US10231963, Table B.8 | US10736890, Compound TABLE B.8 | US11534436, Compound Table B.8 | US9656961, Example 00125 | rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol | ||
Type | Small organic molecule | ||
Emp. Form. | C19H27NO | ||
Mol. Mass. | 285.4238 | ||
SMILES | [#6]-[#6@H]1-[#6@H]-2-[#6]-c3ccc(-[#8])cc3[C@]1([#6])[#6]-[#6]-[#7]-2-[#6]\[#6]=[#6](\[#6])-[#6] |r,TLB:16:15:1:3.4.10| | ||
Structure |